Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Krystal Biotech Inc (KRYS)

Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,819,870
  • Shares Outstanding, K 28,899
  • Annual Sales, $ 290,520 K
  • Annual Income, $ 89,160 K
  • EBIT $ 66 M
  • EBITDA $ 72 M
  • 60-Month Beta 0.79
  • Price/Sales 13.64
  • Price/Cash Flow 29.58
  • Price/Book 4.03

Options Overview Details

View History
  • Implied Volatility 44.52% ( -1.27%)
  • Historical Volatility 59.36%
  • IV Percentile 44%
  • IV Rank 25.19%
  • IV High 75.29% on 08/02/24
  • IV Low 34.16% on 11/14/24
  • Put/Call Vol Ratio 0.48
  • Today's Volume 1,781
  • Volume Avg (30-Day) 418
  • Put/Call OI Ratio 0.54
  • Today's Open Interest 6,355
  • Open Int (30-Day) 5,069

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 1.31
  • Number of Estimates 4
  • High Estimate 1.71
  • Low Estimate 0.95
  • Prior Year 0.86
  • Growth Rate Est. (year over year) +52.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
131.71 +0.36%
on 05/09/25
176.73 -25.21%
on 04/23/25
-35.98 (-21.40%)
since 04/09/25
3-Month
131.71 +0.36%
on 05/09/25
197.94 -33.22%
on 03/25/25
-22.69 (-14.65%)
since 02/07/25
52-Week
131.71 +0.36%
on 05/09/25
219.34 -39.74%
on 07/26/24
-26.56 (-16.73%)
since 05/09/24

Most Recent Stories

More News
Krystal Biotech to Present at BofA Securities 2025 Health Care Conference

KRYS : 132.18 (-3.64%)
Krystal Biotech Announces First Quarter 2025 Financial and Operating Results

KRYS : 132.18 (-3.64%)
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

KRYS : 132.18 (-3.64%)
Krystal Biotech to Present at Upcoming Scientific Conferences

KRYS : 132.18 (-3.64%)
Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025

KRYS : 132.18 (-3.64%)
Fate Therapeutics' Lupus Candidate FT819 Gets FDA RMAT Tag

Fate Therapeutics FATE recently announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its investigational pipeline candidate FT819 for the treatment of active...

KRYS : 132.18 (-3.64%)
JAZZ : 97.78 (-0.64%)
ADMA : 19.98 (-5.75%)
FATE : 1.0400 (+0.97%)
Ironwood Shares Tank on Regulatory Update for Apraglutide

Shares of Ironwood Pharmaceuticals IRWD plunged 31.5% yesterday after it announced regulatory updates on the next-generation GLP-2 analog, apraglutide, which is being developed for treating short bowel...

KRYS : 132.18 (-3.64%)
IRWD : 0.7092 (+1.33%)
JAZZ : 97.78 (-0.64%)
ADMA : 19.98 (-5.75%)
Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate

Arcturus Therapeutics Holdings Inc. ARCT announced that the FDA has granted a Fast Track designation to its self-amplifying mRNA (sa-mRNA) vaccine candidate, ARCT-2304, for active immunization to protect...

KRYS : 132.18 (-3.64%)
JAZZ : 97.78 (-0.64%)
ADMA : 19.98 (-5.75%)
ARCT : 10.98 (-3.51%)
TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why

Shares of TG Therapeutics, Inc. TGTX have rallied 29.5% in the past three months against the industry’s decline of 11.2%.The company’s sole marketed drug Briumvi (ublituximab-xiiy) was approved by...

TGTX : 33.64 (-0.65%)
KRYS : 132.18 (-3.64%)
DTIL : 5.13 (-0.39%)
JAZZ : 97.78 (-0.64%)
Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer

KRYS : 132.18 (-3.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.

See More

Key Turning Points

3rd Resistance Point 146.74
2nd Resistance Point 143.64
1st Resistance Point 137.91
Last Price 132.18
1st Support Level 129.08
2nd Support Level 125.98
3rd Support Level 120.25

See More

52-Week High 219.34
Fibonacci 61.8% 185.87
Fibonacci 50% 175.52
Fibonacci 38.2% 165.18
Last Price 132.18
52-Week Low 131.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar